Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
The DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Background CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is commonly overlooked or misdiagnosed owing to its recent identification and its variable mode of presentation. The defective gene in CADASIL is Notch3, which encodes a large transmembrane receptor. To set up a diagnostic test and to delineate the Notch3 domains involved in CADASIL., we undertook mutations analysis in this gene in a group of CADASIL patients.Methods 50 unrelated patients with CADASIL and 100 healthy controls were screened for mutations along the entire Notch3 sequence, by means of single-strand conformation polymorphism, heteroduplex, and sequence analysis.Findings Strongly stereotyped mis-sense mutations, located within the epidermal-growth-factor-like (EGF-like) repeats, in the extracellular domain of Notch3, were detected in 45 patients. Clustering of mutations within the two exons encoding the first five EGF-like repeats was observed (32 patients). All these mutations lead to loss or gain of a cysteine residue and therefore to an unpaired number of cysteine residues within a given EGF domain. None of these mutations was found in the 100 controls.Interpretation Because of the strong clustering and highly stereotyped nature of the pathogenetic mutations detected in CADASIL patients, and easy and reliable diagnostic test for CADASIL is feasible. The findings suggest that aberrant dimerisation of Notch3, due to abnormal disulphide bridging with another Notch3 molecule or with another protein, may be involved in the pathogenesis of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Self-citationArtavanis-Tsakonas, S., Matsuno, K., & Fortini, M. E. (1995) · Science · doi:10.1126/science.7716513 · Cited by 1,303
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., Mas, J.-L., Cabanis, E.-A., Baudrimont, M., Maciazek, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0393-256 · Cited by 682
Self-citationClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Self-citationRebay, I., Fehon, R. G., & Artavanis-Tsakonas, S. (1993) · Cell · doi:10.1016/0092-8674(93)90423-n · Cited by 409
Epidermal growth factor-like modules
Campbell, I. D., & Bork, P. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80111-3 · Cited by 351
Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., Pruvo, J.-P., Vermersch, P., & Leys, D. (1995) · Acta Neuropathologica · doi:10.1007/bf00571504 · Cited by 329
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.
Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993) · Stroke · doi:10.1161/01.str.24.1.122 · Cited by 321
Self-citation
Research works printed but not linked: 1
- Davous, 1991, Démence sous corticale familiale avec leucoencéphalopathie artériopathique: observation clinicopathologique., Rev Neurol (Paris), 5, 376
Cited by
Items 401–500 of 735
Brulin, P., Godfrain, C., Maurage, C., Reuck, J. D., Hauw, J., Kaltner, H., Bovin, N. V., Gabius, H., Ruchoux, M., Kiss, R., et al. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00478.x · Cited by 13
“Although the main vessel lesions were observed in the tissues depending on the blood‐brain barrier including the brain itself, the optical nerve and the retina [40], GOM deposits surrounding VMCs ‐ a characteristic feature of this disease ‐ were also found in the skin of CADASIL subjects [19, 21 ].”
BackgroundNew Genetic Concepts and Stroke Prevention
Auburger, G. W. J. (1998) · Cerebrovascular Diseases · doi:10.1159/000047515 · Cited by 13
Maász, A., & Melegh, B. (2010) · Genome Medicine · doi:10.1186/gm185 · Cited by 12
Novel and Recurring NOTCH3 Mutations in Two Chinese Patients with CADASIL
Chen, X., Deng, S., Xu, H., Hou, D., Hu, P., Yang, Y. X., Wen, J., Deng, H., & Yuan, L. (2019) · Neurodegenerative Diseases · doi:10.1159/000500166 · Cited by 12
Baron, M. (2017) · Molecular Membrane Biology · doi:10.1080/09687688.2018.1503742 · Cited by 12
“Notch, in particular within EGF modules 1-5 (Joutel et al., 1997).”
BackgroundA novel cysteine-sparing G73A mutation of NOTCH3 in a Chinese CADASIL family
Huang, L., Li, W., Li, Y., Song, C., Wang, P., Wang, H., & Sun, X. (2019) · Neurogenetics · doi:10.1007/s10048-019-00592-3 · Cited by 12
Novel mutation of the Notch3 gene in a Japanese patient with CADASIL
Oki, K., Nagata, E., Ishiko, A., Shimizu, A., Tanaka, K., Takahashi, K., Tabira, T., Katayama, T., & Suzuki, N. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01641.x · Cited by 12
“Generally, the age at onset of CADASIL ranges from 30 to 60 years, with the disease appearing predominantly at around the age of 50 years [1,9].”
BackgroundInfluentialİnce, B., Şenel, G. B., Sıva, A., Saip, S., Utku, U., Çelik, Y., Örken, D. N., Öztürk, Ş., Afşar, N., Aktan, S., et al. (2014) · European Neurology · doi:10.1159/000360530 · Cited by 12
Silent Infarcts Demonstrated by Diffusion-Weighted MRI in CADASIL
Moon, S. Y., Ki, C., Kim, J. W., Suh, Y., Kwon, J. C., & Na, D. L. (2003) · European Neurology · doi:10.1159/000069071 · Cited by 12
Gerritsen, M. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00008-5 · Cited by 12
Two Japanese CADASIL Families with a R141C Mutation in the Notch3 Gene.
Murakami, T., Iwatsuki, K., Hayashi, T., Sato, K., Matsubara, E., NAGANO, I., Manabe, Y., Shoji, M., & Abe, K. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.1144 · Cited by 12
Wilder-Smith, E. P., Shen, Y., Ng, Y. K., Yu, G., Chew, N. K., Tan, C. T., & Wong, M. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2003.05.007 · Cited by 12
Screening British CADASIL families for mutations in theNOTCH3 gene: Table 1
de Lange, R. P. J., BOLT, J., Reid, E., SILVA, R. D., SHAW, D. J., & CLAIR, D. M. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.224 · Cited by 12
Hedera, P., & Turner, R. S. (2002) · Neurologic Clinics · doi:10.1016/s0733-8619(01)00020-2 · Cited by 12
Calcium‐Binding EGF ‐Like Domains
Boswell, E. J., Kurniawan, N. D., & Downing, A. K. (2004) · Wiley eBooks · doi:10.1002/9781119951438.eibc0513 · Cited by 12
Dissecting Polygenic Etiology of Ischemic Stroke in the Era of Precision Medicine
Li, J., Abedi, V., & Zand, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11205980 · Cited by 11
Heidari, P., Taghizadeh, M., & Vakili, O. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02025-z · Cited by 11
“While this may suggest a non-traditional mutation in CADASIL, it could also represent a CADASIL-like syndrome or may not be pathogenic; further investigation is ongoing [67, 70].”
InfluentialReport of two Chinese families and a review of Mainland Chinese CADASIL patients
Yin, X., Ding, M., Zhang, B., Liu, J., Zhang, L., Wang, P., Zhou, F., & Zhao, G. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.011 · Cited by 11
“CADASIL has beenwidely reported in Europe [2,6–14].”
BackgroundResultInfluentialCADASIL syndrome: differential diagnosis with multiple sclerosis
Danchenko, I. Y., Kulesh, A. A., Евгеньевич, Д. В., Kanivets, I. V., Акимова, И. А., & Monak, A. A. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911910128 · Cited by 11
Bowirrat, A., & Shahien, R. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s19399 · Cited by 11
“One of these mutations is a deletion which removes the amino acids between two cysteines, and the remainder are missense mutations leading to one amino acid substitution.(18,19,22,30,32) Whether these substitutions are truly pathogenic mutations or merely polymorphisms is as yet unclear.”
BackgroundBianchi, S., Rufa, A., Ragno, M., D’Eramo, C., Pescini, F., Pantoni, L., Cappelli, A., Perretti, A., Zicari, E., Zolo, P., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5481-z · Cited by 11
“Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a cerebral small vessel disease due to mutations in the NOTCH3 gene, characterized by recurrent stroke, cognitive deterioration, and MRI signal abnormalities of subcortical white matter (WM) [4, 8].”
BackgroundKatanaev, V. L., & Kryuchkov, M. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911130116 · Cited by 11
Hu, L., Liu, G., & Fan, Y. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106541 · Cited by 11
CADASIL: a guide to a comparatively unrecognised condition in psychiatry
Taylor, M. H., & Doody, G. A. (2008) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.004655 · Cited by 11
Two novel mutations of the NOTCH3 gene in Korean patients with CADASIL
Kim, Y., Kim, J. S., Kim, G.-H., No, Y. J., & Yoo, H. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.06.031 · Cited by 11
Progressive neurological deterioration in a child with distal arthrogryposis and whistling face
LEV, D., YANOOV, M., WEINTRAUB, S., & Lerman‐Sagie, T. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.231 · Cited by 11
Andersen, O. M., Monti, G., Jensen, A. M. G., de Waal, M. W. J., Hulsman, M., Olsen, J. G., & Holstege, H. H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.27.524103 · Cited by 11
Monogenic causes of cerebral small vessel disease and stroke
Guey, S., & Chabriat, H. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00018-1 · Cited by 10
Self-citationAdvances in Management of the Stroke Etiology One-Percenters
Osteraas, N. D., & Dafer, R. M. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01269-z · Cited by 10
Ferris, H. R., Stine, N. C., Hill‐Eubanks, D. C., Nelson, M. T., Wellman, G. C., & Koide, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216284 · Cited by 10
“CADASIL is caused by mutations in the extracellular domain of the NOTCH3 gene [16,17], the pathology of which is characterized by small vessel dysfunction in the brain and ultimately leads to cognitive decline [18–20].”
CADASIL presenting with a behavioural variant frontotemporal dementia phenotype
Alexander, S., Brown, J. M., Graham, A., & Nestor, P. J. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.02.025 · Cited by 10
Machine Learning for Alzheimer’s Disease and Related Dementias
Modat, M., Cash, D. M., Canas, L. S., Bocchetta, M., & Ourselin, S. (2023) · Neuromethods · doi:10.1007/978-1-0716-3195-9_25 · Cited by 10
Headache and NOTCH3 Gene Variants in Patients with CADASIL
Szymanowicz, O., Korczowska-Łącka, I., Słowikowski, B. K., Wiszniewska, M., Piotrowska, A., Goutor, U., Jagodziński, P. P., Kozubski, W. P., & Dorszewska, J. (2023) · Neurology International · doi:10.3390/neurolint15040078 · Cited by 10
“Initially described in proliferating neuroepithelium, the NOTCH3 gene and over 70% of mutations in CADASIL have been reported to occur in EGF-like repeats 3 and 4 of the Notch3 extracellular domain [38].”
BackgroundMulti-organ investigation in 16 CADASIL families from central Italy sharing the same R1006C mutation
Ragno, M., Pianese, L., Cacchiò, G., Manca, A., Scarcella, M., Silvestri, S., Marzio, F. D., Caiazzo, A., Silvaggio, F., Tasca, G. A., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.062 · Cited by 10
p.Arg332Cys Mutation of NOTCH3 Gene in Two Unrelated Japanese Families with CADASIL
Sano, Y., Shimizu, F., Kawai, M., Omoto, M., Negoro, K., Kurokawa, T., Fujisawa, H., Suzuki, M., Okayama, N., Suehiro, Y., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5418 · Cited by 10
“Evidence from various sources suggests that the genotype-phenotype correlations in CADASIL are weak (15).”
BackgroundCranial neuralgias and headaches associated with cranial vascular disorders
Chavin, J. M. (2003) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(03)00124-5 · Cited by 10
“CADASIL in European families has been mapped to chromosome 19 [51], and Joutel and others [52] have mapped the disorder to the Notch 3 gene, which is the same gene as that of familial hemiplegic migraine.”
BackgroundCADASIL with a Novel Mutation in Exon 7 of NOTCH3 (C388Y)
Ishida, C., Sakajiri, K., Yoshita, M., Joutel, A., Riant, F., & Yamada, M. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1692 · Cited by 10
“Immunohistochemistry was performed on 8 μm paraffin sections with an anti-Notch3 murine monoclonal antibody, 1E4 (1:5 dilution), raised against epidermal growth factor-like (EGFlike) repeat17-21 (2).”
BackgroundMethodSelf-citationNotch Pathway and Inherited Diseases: Challenge and Promise
Reichrath, J., & Reichrath, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34436-8_9 · Cited by 9
Hydrolysis of a second Asp-Pro site at the N-terminus of NOTCH3 in inherited vascular dementia
Zhang, X., Lee, S. J., & Wang, M. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-96679-9 · Cited by 9
“Notwithstanding this limitation, these studies will stimulate further inquiry to answer unresolved questions that include: (1) Are there specific biochemical conditions in diseased vessels that favor cleavage at Asp-Pro sites? (2) Can other endogenous small polyanionic compounds be used to block Asp-Pro cleavage? (3)…”
BackgroundR54C Mutation of NOTCH3 Gene in the First Rungus Family with CADASIL
Lim, K. S., Tan, A. H., Lim, C. S., Chua, K. H., Lee, P.-C., Ramli, N. M., Rajahram, G. S., Hussin, F. T., Wong, K. T., Bhattacharjee, M. B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135470 · Cited by 9
No vessel wall abnormalities in a human foetus with a NOTCH3 mutation
Oberstein, S. A. J. L., Maat–Schieman, M. L. C., Boon, E. M. J., Haan, J., Breuning, M. H., & van Duinen, S. G. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0335-1 · Cited by 9
“and caused by mutations in the NOTCH3 gene [1].”
BackgroundGenetics of Ischaemic Stroke; Single Gene Disorders
Floßmann, E. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00037.x · Cited by 9
Sharma, P., Wang, T., Brown, M. J., & Schapira, A. H. V. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05331-4 · Cited by 9
Early remodeling and loss of light-induced dilation of retinal small arteries in CADASIL
Pâques, M., Krivosic, V., Castro‐Farías, D., Dulière, C., Hervé, D., Chaumette, C., Rossant, F., Taleb, A., Lebenberg, J., Jouvent, É., et al. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241226484 · Cited by 8
Self-citationThe Pathobiology of Cerebrovascular Lesions in CADASIL Small Vessel Disease
Joutel, A. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70028 · Cited by 8
Self-citationLunatic fringe promotes the aggregation of CADASIL NOTCH3 mutant proteins
Suzuki, S., Hiura, S., Mashiko, T., Matsumoto, T., & Itoh, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.031 · Cited by 9
NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype
Almeida, M. R., Elias, I., Fernandes, C., Machado, R., Galego, O., & Santo, G. (2021) · Neurogenetics · doi:10.1007/s10048-021-00679-w · Cited by 8
“as a polymorphism once it was found in co-occurrence with other known pathogenic NOTCH3 mutation [16, 45].”
BackgroundMonogenic basis of young-onset cryptogenic stroke: a multicenter study
Yuan, W., Shang, L., Tian, D., Wu, S., You, Y., Tian, C., Wu, B. C., Liu, J., Sun, Q., Liu, Q., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-3843 · Cited by 8
Novel loci for Alzheimer's disease identified by a genome‐wide association study in Ashkenazi Jews
Li, D., Farrell, J. J., Mez, J., Martin, E. R., Bush, W. S., Ruiz, A., Boada, M., de Rojas, I., Mayeux, R. P., Haines, J. L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13117 · Cited by 8
Takahashi, K., Adachi, K., Kunimoto, S., Wakita, H., Takeda, K., & Watanabe, A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.105 · Cited by 8
Imaging‐based pregenetic screening for NOTCH3 p.R544C mutation in ischemic stroke in Taiwan
Cheng, Y., Chen, C., Hu, C., Chiou, H., Tang, S., & Jeng, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51191 · Cited by 8
“There are more than 200 documented pathogenic mutations, most of which are alternations of the number of cysteine residues in the conserved epidermal growth factor-like repeat (EGFR) domains.(2,3) Across different ethnic groups, there are considerable variations in the NOTCH3 mutation frequency and the dominant mutati…”
BackgroundMönkäre, S., Kuuluvainen, L., Schleutker, J., Myllykangas, L., & Pöyhönen, M. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13703 · Cited by 8
Mizuno, T., Makino, M., FUJIWARA, Y., & Nakajima, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04823.x · Cited by 8
Donnini, I., Rinnoci, V., Nannucci, S., Valenti, R., Pescini, F., Mariani, G., Bianchi, S., Dotti, M. T., Federico, A., Inzitari, D., et al. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12784 · Cited by 8
Masoli, J. A. H., Pilling, L. C., Kuchel, G. A., & Melzer, D. R. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0671-6 · Cited by 8
“Previous CADASIL studies have generally involved genotyping for patients presenting with repeated strokes, with several missense (amino-acid substituting) mutations in the NOTCH3 gene reported [3].”
BackgroundAssociation of NOTCH3 Gene Polymorphisms with Ischemic Stroke and Its Subtypes: A Meta-Analysis
Wei, L. K., Griffiths, L. R., Looi, I., & Kooi, C. W. (2019) · Medicina · doi:10.3390/medicina55070351 · Cited by 8
“An equal number of cysteine residues in the extracellular domain are linked by three disulphide bridges, in order to form a stable secondary epidermal growth factor-like structure [4].”
BackgroundInfluentialCalcium-Binding EGF-like Domains
Downing, A. K., Handford, P. A., & Campbell, I. D. (2000) · Springer eBooks · doi:10.1007/978-3-642-58306-3_4 · Cited by 8
NOTCH3 Variant Position Affects the Phenotype at the Pluripotent Stem Cell Level in CADASIL
Bugallo-Casal, A., Muiño, E., Bravo, S. B., Hervella, P., Rivas, S. A., Rodríguez‐Yáñez, M., Vara-León, E., Quintas‐Rey, R., Pérez-Gayol, L., Maisterra, O., et al. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08840-6 · Cited by 7
“NECD was more aggregated around the plasma membrane (Fig.”
InfluentialIs migraine a common manifestation of CADASIL? Arguments Pros
Chabriat, H. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01980-x · Cited by 7
“The disease is caused by cysteine mutations in the NOTCH3 gene, leading to a progressive accumulation of extracellular domains (ECD) of the NOTCH3 protein in the wall of cerebral arterioles and capillaries [4, 5].”
Self-citationThe role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies
Felix-Ilemhenbhio, F., Kocsy, K., Azzouz, M., & Majid, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149754 · Cited by 7
Dunn, P. J., Lea, R. A., Maksemous, N., Smith, R. A., Sutherland, H. G. E., Haupt, L. M., & Griffiths, L. R. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03039-3 · Cited by 7
“Mutations in NOTCH3 which alter cysteines within exons 2–24 encompassing the epidermal growth factorlike repeats (EGFRs) were originally identified as causal in CADASIL patients [6].”
BackgroundGenetic study of the NOTCH3 gene in CADASIL patients
Tarzjani, S. P. C., Fazeli, S. A. S., Sanati, M. H., & Mirzayee, Z. (2018) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2018.05.001 · Cited by 7
Lačković, V., Bajčetić, M., Lačković, M., Novaković, I. V., Labudović‐Borović, M., Pavlovic, A. M., Zidverc-Trajkovic, J. J., Dzolic, E., Rovčanin, B., Šternić, N., et al. (2012) · Ultrastructural Pathology · doi:10.3109/01913123.2012.679352 · Cited by 7
“However, it is unknown whether these polymorphisms affect Notch3 signaling or whether they are involved in cerebrovascular disease [42,43].”
BackgroundGenetic Study of Cerebral Small Vessel Disease in Chinese Han Population
Wang, Y., Shi, C., Li, Y., Yu, W.-K., Wei, S., Fan, Y., Mao, C., Yang, Z., Yu, L.-L., Zhao, Z., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.829438 · Cited by 7
Diagnosis, pathomechanism and treatment of CADASIL
Mizuno, T. (2012) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.52.303 · Cited by 7
Yadav, S., Bentley, P., Srivastava, M. V. P., Prasad, K., & Sharma, P. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.05.023 · Cited by 7
de Silva, K. R. D., Gamage, R., Dunuwille, J., Gunarathna, D., Sirisena, D., Weerasinghe, A., Amarasinghe, P., Hosomi, A., & Mizuno, T. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.01.019 · Cited by 7
“Over 130 different mutations in the NOTCH3 gene have been described in patients with CADASIL and around 70% of the mutations cluster in exons 3 and 4.(5) Of the three patients with CADASIL reported from the Indian subcontinent, the Indian study(4) reported a heterozygous mutation in exon 4 resulting in an R141C mutati…”
BackgroundDichgans, M. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203008913 · Cited by 7
Notch Signaling and the Emergence of Auditory Hair Cells
Weir, J., Rivolta, M. N., & Holley, M. C. (2000) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.126.10.1244 · Cited by 7
Suzuki, S., Mashiko, T., Tsukamoto, Y., Oya, M., Kotani, Y., Okawara, S., Matsumoto, T., Mizue, Y., Takeuchi, H., Okajima, T., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107787 · Cited by 6
“Most CADASIL-associated point mutations result in an odd number of cysteine residues within an EGFr of the N3ECD (19).”
BackgroundZhao, Y., Lu, Y., Wang, F., Wang, Y., Li, Y., Sun, R., Shang, J., Jiang, C. Q., & Zhang, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1573052 · Cited by 6
Targeted exonic sequencing identifies novel variants in a cerebral small vessel disease cohort
Dunn, P. J., Maksemous, N., Smith, R. A., Sutherland, H. G. E., Haupt, L. M., & Griffiths, L. R. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120120 · Cited by 6
Cell‐to‐Cell Communication and Vascular Dementia
Dietrich, H. H. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00175.x · Cited by 6
“They subsequently label it as VaD when both cognitive impairment and imaging evidence of vascular disease is confirmed such as a stroke and onset of dementia or evidence of subcortical cerebrovascular disease such as CADASIL, which is an autosomal dominant arteriopathy characterized by a Notch3 gene mutation that resu…”
BackgroundNotch3 gene in CADASIL syndrome: mutation frequencies in Japanese and its expression and processing
Takahashi, K., Kotorii, S., Chui, D., Shirotani, K., & Tabira, T. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8225-5_24 · Cited by 6
Hallazgos clínicos y de neuroimagen en una familia con CADASIL asociada a la mutación C475T
Sempere, Á. P., Pérez‐Tur, J., Barragán, N. G., Martínez, J. S., Martínez, V. M., & de Rodas, S. M. C. (2004) · Revista de Neurología · doi:10.33588/rn.3801.2003328 · Cited by 6
Mendelian and mitochondrial disorders associated with stroke
Silliman, S. L. (2002) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2002.129614 · Cited by 6
Investigation of the NOTCH3 and TNFSF7 Genes on C19p13 as Candidates for Migraine
Smith, R. A., Curtain, R. P., Ovcaric, M., Tajouri, L., MacMillan, J., & Griffiths, L. R. (2008) · The Open Neurology Journal · doi:10.2174/1874205x00802010001 · Cited by 6
“Mutations identified to date in NOTCH3 have all been missense mutations involving a loss or gain of a cysteine amino acid residue [13].”
BackgroundInfluentialRagno, M., Cacchiò, G., Fabrizi, G. M., Scarcella, M., Silvaggio, F., Cavallaro, T., Taioli, F., & Trojano, L. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0817-x · Cited by 6
“[12], could result in confirmation of CADASIL only in one”
BackgroundAu, K.-M., Li, H.-L., Sheng, B., Chow, T., Chen, M.-L., Lee, K.-C., & Chan, A. Y. W. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.022 · Cited by 6
Chuah, T., Tan, K. M., Flanagan, S., Hyland, V. J., Sullivan, A., Henderson, R. A., MacMillan, J., & Lander, C. M. (2001) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2000.0848 · Cited by 6
Diener, H., Welch, K. M. A., & Mohr, J. P. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50033-x · Cited by 6
Cell - Cell and Cell - Matrix Interactions
Fernández, B., & Broich, K. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-8126-x_9 · Cited by 6
Lee, S. J., Kondepudi, A., Young, K. Z., Zhang, X., Cartee, N. M. P., Chen, J., Jang, K. Y., Xu, G., Borjigin, J., & Wang, M. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281094 · Cited by 5
“CADASIL is caused by mutations in NOTCH3 that result in a change in the number of cysteine residues in the gene product [7, 8].”
BackgroundChen, Y.-C., Hsiao, C.-T., Soong, B., & Lee, Y. (2014) · PubMed · Cited by 5
7T MRI in cerebrovascular disorders: From large artery abnormalities to small vessel disease
Wang, W., Lyu, J., Wang, X., Duan, Q., Li, R., Bian, X., Duan, C., Wang, S., Xing, X., & Lou, X. (2024) · Meta-Radiology · doi:10.1016/j.metrad.2024.100085 · Cited by 5
Tung, H., Chou, C., Chen, H.-M., Chen, Y., Wu, Y.-Y., Chai, J., Chen, J.-P., Chen, S., Chen, H.-C., & Lee, W. (2024) · Neurology · doi:10.1212/wnl.0000000000209941 · Cited by 5
Notch3 is an asymmetric gene and a modifier of heart looping defects in Nodal mouse mutants
Bønnelykke, T. H., Chabry, M.-A., Perthame, É., Dombrowsky, G., Berger, F. F., Dittrich, S., Hitz, M., Desgrange, A., & Meilhac, S. M. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002598 · Cited by 5
“Gain-of-function of NOTCH3 in CADASIL syndrome is responsible for smooth muscle degeneration in the brain [40,43,44].”
Zhou, L. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0303-2 · Cited by 5
“Most mutations found in CADASIL syndrome localize to the Notch3 epidermal growth factor (EGF) repeats, with some involved in the ligand binding domain [10].”
BackgroundAssociation between NOTCH3 gene and Parkinson’s disease based on whole-exome sequencing
Zeng, Q., Pan, H., Zhao, Y., Wang, Y., Xu, Q., Tan, J., Yan, X., Li, J., Tang, B., & Guo, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.995330 · Cited by 5
“Virtually all CADASIL mutations lead to the loss or addition of a cysteine residue and therefore to an odd number of cysteine residues within a given EGFr domain (Joutel et al., 1997).”
BackgroundThe Dawn and Advancement of the Knowledge of the Genetics of Migraine
Zalaquett, N., Salameh, E., Kim, J. M., Ghanbarian, E., Tawk, K., & Abouzari, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092701 · Cited by 5
Genetic Risk Factors for Dementia
Hollingworth, P., & Williams, J. H. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch6 · Cited by 5
Ultrastructural analysis of small blood vessels in skin biopsies in CADASIL
Lačković, V., Bajčetić, M., Šternić, N., Kostić, V., Jj, Z., Pavlovic, A. M., Lačković, M., & Kočica, M. J. (2008) · Archives of Biological Sciences · doi:10.2298/abs0804573l · Cited by 5
Reversed flow in the basilar artery in acute vertebrobasilar ischemia
Sharma, V. K., Teoh, H. L., Chan, B. P. L., & Ong, B. K. C. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.01.024 · Cited by 5
Ruchoux, M. (2004) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/j.scds.2004.10.004 · Cited by 5
Mizuno, T., Mizuta, I., & Tomimoto, H. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000445499 · Cited by 5
Novel heterozygous NOTCH3 pathogenic variant found in two Chinese patients with CADASIL
Li, S., Chen, Y., Shan, H., Ma, F., Shi, M., & Xue, J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.08.029 · Cited by 5
“For example, no NOTCH3 mutation is identifiable in 5–10% of GOM-positive CADASIL patients [4,22].”
Notch3 and its CADASIL mutants differentially regulate cellular phenotypes
Lin, C., Huang, Z., Zhou, R., Zhou, Y., Shentu, Y., Kang, Y., & Zhang, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9549 · Cited by 5
“Most of these are missense point mutations complemented by a few small dele‐ tions that lead to gain or loss of a cysteine residue within an epidermal growth factor‐like domain, thus altering the number of cysteine residues within a given domain from 6 to either 5 or 7 (6).”
BackgroundXu, Y., Kavvadas, P., Keuylian, Z., Hertig, A., Rondeau, É., & Chatziantoniou, C. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17325 · Cited by 5
A Next-Generation Sequencing of the NOTCH3 and HTRA1 Genes in CADASIL Patients
Fernández-Iglesias, Á., Gómez, J., Alonso, B., Iglesias, S., & Coto, E. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0560-3 · Cited by 5
An Italian case of CADASIL with mutation CGC-TCG in codon 1006, exon 19 Notch3 gene
Guidetti, D., Casali, B., Mazzei, R., Cenacchi, G., Berti, G. D., Zuccoli, G., Nicoli, D., Conforti, F. L., Sprovieri, T., Pasquinelli, G., et al. (2004) · Neurological Sciences · doi:10.1007/s10072-003-0196-x · Cited by 5
Metadata
- Authors
- Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., Bach, J.-F., & Tournier-Lasserve, E.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Lariboisière (FR)
- bioMérieux (France) (FR)
- Genethon (France) (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1511-1515
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153287135
- Cited by
- 682
- References
- 26
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 27 · 2021: 16 · 2020: 30 · 2019: 20 · 2018: 28 · 2017: 16 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CADASIL, Notch3, NOTCH3 mutations, EGF-like repeats, mutation clustering, diagnostic testing, cerebrovascular disease, leukoencephalopathy
- MeSH terms
- Receptor, Notch3, Cerebral Arterial Diseases, Cerebral Infarction, DNA Mutational Analysis, Epidermal Growth Factor, Genetic Testing, Genotype, Humans, Leukoencephalopathy, Progressive Multifocal, Mutation, Proto-Oncogene Proteins, Receptors, Cell Surface, Case-Control Studies, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.